LEO 138559
LEO Pharma,argenx
['leo 138559', 'atopic dermatitis ', 'derm', 'leo pharma']
leo pharma presents late-breaking positive phase 2a efficacy and safety results of leo 138559 in moderate-to-severe atopic dermatitis at the 2023 aad annual meeting - -
MD MSC CPDS https://t.co/YL6HxBReRh https://t.co/kePCRsN4Gw  https://t.co/t7oxnCVsEI  #cardiology  #AI #informatics #healthcare #innovation #Data